Status:

COMPLETED

A Trial of Rosuvastatin in Systemic Lupus Erythematosus

Lead Sponsor:

Imperial College London

Conditions:

Atherosclerosis

Systemic Lupus Erythematosus

Eligibility:

All Genders

18-80 years

Phase:

PHASE2

Brief Summary

Systemic Lupus Erythematosus (SLE) is a condition that affects the whole body. It can cause inflammation of the blood vessels resulting in an earlier thickening and hardening of the arteries resulting...

Detailed Description

Systemic lupus erythematosus (SLE) is an auto-immune condition, multisystem, connective tissue disorder with a wide spectrum of disease (D'Cruz et al 2007), which includes cardiovascular manifestation...

Eligibility Criteria

Inclusion

  • Subjects with SLE-as diagnosed by ACR criteria
  • Male or females who are 18-80years of age, inclusive at screening
  • Female subjects who are post menopausal (i.e \>6mnths without menstrual period), surgically sterile, or using effective contraceptive measures at visit 0 and the same contraception throughout the study and for 30days after discontinuing treatment
  • No current or previous statin therapy
  • No current indication for statin therapy (Coronary artery disease; hypercholesterolemia, renal dysfunction)
  • Subjects who have given their signed consent to participate in the study

Exclusion

  • Patient \< 18 or \> 80 years
  • Contraindications for MRI - patients with pacemakers' defibrillators or pacing wires in the heart, or other metal implants such as metal in the eye, brain or spine. Other metallic devices or implants will have to be declared by the participant and assessed to be safe prior to having an MRI current or previous statin
  • Known atherosclerotic valvular disease
  • Renal dysfunction
  • Hyperlipidemia
  • Active myositis
  • All forms of liver disease
  • Pregnancy
  • Breastfeeding
  • Patients being treated with Cyclosporin A

Key Trial Info

Start Date :

July 1 2010

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2014

Estimated Enrollment :

33 Patients enrolled

Trial Details

Trial ID

NCT01170585

Start Date

July 1 2010

End Date

June 1 2014

Last Update

June 23 2015

Active Locations (2)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (2 locations)

1

Imperial College NHS Trust

London, London, United Kingdom

2

North West London Hospitals NHS Trust

London, London, United Kingdom

A Trial of Rosuvastatin in Systemic Lupus Erythematosus | DecenTrialz